These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6982763)

  • 1. Indomethacin-responsive mononuclear cell dysfunction in "atypical" mycobacteriosis.
    Mason UG; Greenberg LE; Yen SS; Kirkpatrick CH
    Cell Immunol; 1982 Jul; 71(1):54-65. PubMed ID: 6982763
    [No Abstract]   [Full Text] [Related]  

  • 2. Improvement of abnormal lymphocyte responses in "atypical" mycobacteriosis with indomethacin.
    Mason UG; Greenberg LE; Yen SS; Kirkpatrick CH
    Adv Exp Med Biol; 1983; 162():197-205. PubMed ID: 6408901
    [No Abstract]   [Full Text] [Related]  

  • 3. Modulation of immunologic responses in nontuberculous mycobacterial infections with indomethacin.
    Mason UG; Kirkpatrick CH
    J Clin Immunol; 1984 Mar; 4(2):112-7. PubMed ID: 6725531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen-specific T-cell anergy in progressive Mycobacterium marinum infection in humans.
    Dattwyler RJ; Thomas J; Hurst LC
    Ann Intern Med; 1987 Nov; 107(5):675-7. PubMed ID: 3499107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the mitogenic response of lymphocytes from young and aged individuals by prostaglandins and indomethacin.
    Rao KM; Schwartz SA; Good RA
    Cell Immunol; 1979 Nov; 48(1):155-65. PubMed ID: 509534
    [No Abstract]   [Full Text] [Related]  

  • 6. Indomethacin-mediated enhancement of lymphocyte response to mitogens in healthy subjects and lung cancer patients.
    Han T; Takita H
    Cancer; 1980 Dec; 46(11):2416-20. PubMed ID: 6969110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycobacterium fortuitum infection: evidence of bactericidal defect due to hyperactive antigen-specific suppressor cells. Correction in vitro and in vivo by cholinergic agonist and indomethacin.
    Gardner JD; Ousley M; Godfrey W; Lindsey NJ; Abdou NI
    Am J Med; 1982 Nov; 73(5):756-64. PubMed ID: 6182796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of T lymphocyte proliferative response to mitogens by indomethacin in breast and colorectal cancer patients.
    Han T; Nemoto T; Ledesma EJ; Bruno S
    Int J Immunopharmacol; 1983; 5(1):11-5. PubMed ID: 6601630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunomodulating role of endogenous thyroid hormones in mycobacterioses].
    Balybin ES
    Probl Tuberk; 1995; (2):37-9. PubMed ID: 7777462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressor adherent cells in human tuberculosis.
    Ellner JJ
    J Immunol; 1978 Dec; 121(6):2573-9. PubMed ID: 309907
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostaglandin-dependent regulation of the in vitro proliferative response to mycobacterial antigens of peripheral blood lymphocytes from normal donors and from patients with tuberculosis or leprosy.
    Bahr GM; Rook GA; Stanford JL
    Clin Exp Immunol; 1981 Sep; 45(3):646-53. PubMed ID: 7039874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of indomethacin on T lymphocyte stimulation.
    Kingston AE; Ivanyi J; Kay JE
    Immunol Lett; 1984; 8(6):301-5. PubMed ID: 6335488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indomethacin sensitive suppressor cells in Crohn's disease: a possible role in decreased lymphocyte responsiveness.
    Victorino RM
    J Clin Lab Immunol; 1983 Aug; 11(4):197-201. PubMed ID: 6230454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of suppression of the depressed lymphocyte response in lung cancer patients.
    Alberola V; González-Molina A; Trenor A; San Martín B; Lluch A; Palau F; Marín J; García-Conde FJ
    Allergol Immunopathol (Madr); 1985; 13(3):213-9. PubMed ID: 2931010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of lymphocyte responses by tuberculous plasma and mycobacterial arabinogalactan. Monocyte dependence and indomethacin reversibility.
    Kleinhenz ME; Ellner JJ; Spagnuolo PJ; Daniel TM
    J Clin Invest; 1981 Jul; 68(1):153-62. PubMed ID: 6972952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indomethacin enhancement of immunocompetence in melanoma patients.
    Tilden AB; Balch CM
    Surgery; 1981 Jul; 90(1):77-84. PubMed ID: 6972628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell-dependent polyclonal activation by soluble mycobacterial extracts of B cells in peripheral blood mononuclear cell populations from leprosy patients and normal donors.
    Fleming B; Rook GA
    Immunology; 1982 Dec; 47(4):589-95. PubMed ID: 6183191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro effect of indomethacin on mitogen-induced lymphoproliferative response in lung cancer patients.
    Stanojević-Bakić N; Vucković-Dekić L; Susnjar S; Spuzić I
    Neoplasma; 1992; 39(2):129-32. PubMed ID: 1326720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The suppression of mitogen- and alloantigen-stimulated peripheral blood lymphocytes by cultured human T lymphocytes.
    Maca RD; Bonnard GD; Herberman RB
    J Immunol; 1979 Jul; 123(1):246-51. PubMed ID: 156232
    [No Abstract]   [Full Text] [Related]  

  • 20. PPD testing as a diagnostic aid in non-tuberculous mycobacteriosis. Clinical and immunological investigations in 4 children with cervical lymphadenitis.
    Hallberg A; Hallberg T; Holmberg L
    Acta Paediatr Scand; 1980 Jul; 69(4):511-6. PubMed ID: 6969522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.